A detailed history of Foster Group, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Foster Group, Inc. holds 2,203 shares of NVO stock, worth $226,093. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,203
Previous 2,173 1.38%
Holding current value
$226,093
Previous $310,000 15.48%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$119.07 - $145.42 $3,572 - $4,362
30 Added 1.38%
2,203 $262,000
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $4,662 - $5,582
38 Added 1.78%
2,173 $310,000
Q1 2024

Apr 09, 2024

BUY
$102.11 - $135.92 $218,004 - $290,189
2,135 New
2,135 $274,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Foster Group, Inc. Portfolio

Follow Foster Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Foster Group, Inc. with notifications on news.